The decision to place cochlear implants in both ears at the same time in young children may better shape brain development ...

"A new adventure of having to get a cochlear implant. I was scared. But once I met Dr. Sweeney and Dr. Schadt, I knew there was nothing to worry about. I have never in my life met such supporting ...

VALENCIA, CA / ACCESS Newswire / April 14, 2026 / Advanced Bionics (AB), a global leader in cochlear implant technology, today announced an equity investment and research collaboration with Spiral ...

MPR spoke with Dr Daniela Carvalho, an investigator in the CHORD trial, the results form which formed the basis for the approval of Otarmeni.

After struggling to adapt through school and adult life, Lucy was offered a new procedure at Colchester Hospital. The mum-of-three went through a major surgery, making her the first person to have the ...

The Food and Drug Administration on Thursday approved Regeneron’s Otarmeni, the first gene therapy for genetic hearing loss ...

Heather Porter overcame profound hearing loss and surgeries — all while raising 11 kids — to earn her master's. Her story ...

The FDA has granted accelerated approval to Otarmeni™ (lunsotogene parvec-cwha), the first gene therapy for pediatric and adult patients with OTOF-related sensorineural hearing loss.

Detailed price information for Envoy Medical Inc (COCH-Q) from The Globe and Mail including charting and trades.

The agency's decision is based on results from a clinical trial in which the treatment improved hearing in 80 percent of the ...

The world’s first clinical trial on congenital deafness gene therapy showed that injecting a missing gene back into ear cells ...